This afternoon we watched UnitedHealth drop -1.4% to a price of $475.84 per share. The large-cap Medical Specialities company is now trading -18.58% below its average target price of $584.43. Analysts have set target prices ranging from $514.0 to $650.0 per share for UnitedHealth, and have given the stock an average rating of buy.
UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.5%. The stock's short ratio is 1.3. The company's insiders own 0.27% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 90.0%. In conclusion, we believe there is mixed market sentiment regarding UnitedHealth.
Institutions Invested in UnitedHealth
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-03-31 | Vanguard Group, Inc. (The) | 9% | 84,333,380 | $40,129,195,230 |
| 2023-03-31 | Blackrock Inc. | 8% | 74,928,539 | $35,653,995,723 |
| 2023-03-31 | FMR, LLC | 5% | 45,515,091 | $21,657,900,734 |
| 2023-03-31 | State Street Corporation | 5% | 45,548,879 | $21,673,978,416 |
| 2023-03-31 | Price (T.Rowe) Associates Inc | 3% | 31,591,890 | $15,032,684,821 |
| 2023-03-31 | Capital World Investors | 3% | 29,385,548 | $13,982,819,052 |
| 2023-03-31 | Wellington Management Group, LLP | 3% | 24,079,140 | $11,457,817,889 |
| 2023-03-31 | JP Morgan Chase & Company | 2% | 19,864,394 | $9,452,273,168 |
| 2023-03-31 | Geode Capital Management, LLC | 2% | 17,101,395 | $8,137,527,734 |
| 2023-03-31 | Morgan Stanley | 2% | 14,933,381 | $7,105,899,960 |
